Results 11 to 20 of about 48,847 (353)

Failure of diltiazem to prevent 1:1 conduction of atrial flutter: a case report

open access: yesJournal of Medical Case Reports, 2023
Background Atrial flutter with 1:1 conduction to the ventricles is a dangerous cardiac arrhythmia. Contemporary guidelines recommend atrioventricular nodal blocking agents should be co-administered with class 1C anti-arrhythmics, as prophylaxis against 1:
K. D. Tiver   +4 more
doaj   +1 more source

Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling [PDF]

open access: yes, 2003
<b>Objective:</b> Chronic beta-adrenoceptor antagonist (β-blocker) treatment reduces the incidence of reversion to AF in patients, possibly via an adaptive myocardial response.
Kane, K.A.   +4 more
core   +1 more source

Intravenous Amiodarone versus Digoxin in Atrial Fibrillation Rate Control; a Clinical Trial

open access: yesEmergency, 2016
Introduction: Treatment of rapid ventricular response arterial fibrillation (rapid AF) varies depending on the decision of the in-charge physician, condition of the patient, availability of the drug, and the treatment protocol of the hospital.
Majid Shojaee   +4 more
doaj   +1 more source

Selecting patients with nonischemic dilated cardiomyopathy for ICDs [PDF]

open access: yes, 2017
No abstract ...
Cleland, John G.F.   +2 more
core   +1 more source

Real-practice thromboprophylaxis in atrial fibrillation [PDF]

open access: yes, 2017
This retrospective observational study was based on databases of the Local Health Authority of Treviso, Italy. It evaluated the prevalence and the effectiveness of oral anticoagulation treatment (OAT) for the management of nonvalvular atrial fibrillation
Bettiol, Alessandra   +8 more
core   +2 more sources

Gap junction reduction in cardiomyocytes following transforming growth factor- beta treatment and Trypanosoma cruzi infection [PDF]

open access: yes, 2009
Gap junction connexin-43 (Cx43) molecules are responsible for electrical impulse conduction in the heart and are affected by transforming growth factor-beta (TGF-beta).
Becker, D   +6 more
core   +2 more sources

Intravenous Amiodarone versus Digoxin in Atrial Fibrillation Rate Control; a Clinical Trial

open access: yesArchives of Academic Emergency Medicine, 2017
Introduction: Treatment of rapid ventricular response arterial fibrillation (rapid AF) varies depending on the decision of the in-charge physician, condition of the patient, availability of the drug, and the treatment protocol of the hospital.
Majid Shojaee   +4 more
doaj   +1 more source

Ventricular Arrhythmias in First Acute Myocardial Infarction: Epidemiology, Mechanisms, and Interventions in Large Animal Models

open access: yesFrontiers in Cardiovascular Medicine, 2019
Ventricular arrhythmia and subsequent sudden cardiac death (SCD) due to acute myocardial infarction (AMI) is one of the most frequent causes of death in humans.
Stefan Michael Sattler   +8 more
doaj   +1 more source

Extrahepatic complications of liver transplantation. [PDF]

open access: yes, 1985
The massive surgical assault associated with hepatic transplantation makes a high frequency of complications almost inevitable. In this review of 225 patient records, selected at random from cases of liver transplantation in Pittsburgh over a 2 1/2 year ...
Shaw, BW, Starzl, TE, Wood, RP
core   +1 more source

A multicenter retrospective cohort study on predicting the risk for amiodarone pulmonary toxicity

open access: yesBMC Pulmonary Medicine, 2022
Background Amiodarone is one of the most commonly used anti-arrhythmic agents. Amiodarone pulmonary toxicity is a potentially fatal adverse effect associated with amiodarone use.
Wang Chun Kwok   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy